Efficacy & Toxicity Case Studies

Our innovative gene-editing technology increases gene-editing efficiency by 10 to 20 fold, making
our custom model development process faster and more affordable for your research.

In addition to our expertise in evaluating efficacy of novel antibody drugs, Biocytogen is known for its high quality in vivo toxicity studies. We offer toxicity analyses as both independent offerings and in support of in vivo efficacy studies, which include:

  • Animal clinical observations
  • Complete blood count (CBC)
  • Blood chemistry analysis
  • Histopathology (FFPE block preparation, H&E, IHC)
  • On-mechanism toxicity assays
Back to top